Thibaut Mongon
Also at Kenvue Inc
About
Thibaut Mongon began his career at Johnson & Johnson in 2000, starting as Director of Marketing for the Vision Care group in France. Over the ensuing years, he advanced through a series of leadership roles, moving from the Pharmaceutical sector—where he served as Global Commercial Strategy Leader for the Neuroscience therapeutic area—to the Consumer Health sector, where he eventually held positions such as Company Group Chairman Asia-Pacific and Executive Vice President and Worldwide Chairman, Consumer Health.
Before his tenure at Johnson & Johnson, he gained valuable experience working at prominent companies like Bormioli in Italy and Danone in France, broadening his expertise across international markets.
Beyond his corporate roles, he contributes actively to industry initiatives by serving on the board of directors of The Consumer Goods Forum and as a member of the Business Roundtable, where he brings a wealth of experience and a strategic, consumer-focused perspective.
$KVUE Performance Under Thibaut Mongon
Past Roles
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Johnson & Johnson | Executive Vice President and Worldwide Chairman, Consumer Health | 2019 | Former leadership role prior to joining KVUE |
| Johnson & Johnson | Company Group Chairman Asia-Pacific, Consumer Health | 2014 | Former leadership role |
| Johnson & Johnson | Global Commercial Strategy Leader, Neuroscience | 2012 | Former leadership role in the Pharmaceutical sector |
| Johnson & Johnson | Director of Marketing, Vision Care (France) | 2000 | Initial leadership role in France |
| Bormioli | N/A | N/A | Worked at Bormioli prior to joining Johnson & Johnson |
| Danone | N/A | N/A | Worked at Danone prior to joining Johnson & Johnson |
External Roles
| Organization | Role | Date Range | Details |
|---|---|---|---|
| The Consumer Goods Forum | Board of Directors | N/A | Current active board membership |
| Business Roundtable | Member | N/A | Current active membership |
Fixed Compensation
| Component Name [Citation] | Amount [Citation] | Payment Schedule [Citation] | Additional Details [Citation] |
|---|---|---|---|
| Base Salary | $1,250,000 | Annual, effective January 1, 2023 | Approved base salary for 2023 |
| Registrant Contributions to Defined Contribution Plans | $14,758 | As per plan contributions | Contributions to the 401(k) Savings Plan |
| Non-Qualified Deferred Compensation - Registrant Contributions | $41,119 | As per deferred compensation plan | Contributions to the Excess Savings Plan account |
| Perquisites and Other Personal Benefits | $13,016 | Varies | Includes company car, home security-related costs, life insurance premiums, and travel reimbursement |
Performance Compensation
Annual Incentive (Non-Equity Incentive Plan Awards)
| Metric [USD] | Amount [Citation] |
|---|---|
| Threshold Payout | $1,062,500 |
| Target Payout | $2,125,000 |
| Maximum Payout | $4,250,000 |
| Earned Payout | $2,018,750 |
- Performance Metrics: Based on a combination of business performance (95% of target) and individual performance (N/A).
- Evaluation & Payment: Award is cash-based with payout determined by achievement level; no vesting schedule applies.
December 2023 PSUs (Equity Incentive Plan Awards)
| Metric [Unit/Date] | Details [Citation] |
|---|---|
| Grant Date | December 7, 2023 |
| Grant Date Fair Value | $1,385,434 |
| Grant Date Stock Price | $20.81 |
| Target PSUs Granted | 52,859 shares |
| Maximum PSUs Granted | 105,718 shares |
| Performance Metric | Relative TSR (Evaluation period: December 1, 2023 to November 30, 2026) |
| Payout Threshold | 30th percentile → 50% of target payout |
| Payout Target | 55th percentile → 100% of target payout |
| Payout Maximum | 80th percentile or better → 200% of target payout (capped at 100% if TSR is negative) |
| Vesting Schedule | December 1, 2026 |
| Additional Condition | Dividend equivalents accrue and are reinvested in additional PSUs |